Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. (Q53089386)

11 May 2018

title

Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance. (English)

1 reference

11 May 2018

1 reference

1 reference

2

1 reference

11 May 2018

Alfred King-Yin Lam

6

1 reference

11 May 2018

author name string

Faeza Ebrahimi

1

1 reference

11 May 2018

Riajul Wahab

3

1 reference

11 May 2018

Cu-Tai Lu

4

1 reference

11 May 2018

Robert Anthony Smith

5

1 reference

11 May 2018

language of work or name

English

0 references

publication date

9 October 2015

1 reference

11 May 2018

Experimental Cell Research

published in

1 reference

11 May 2018

volume

339

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

333-341

1 reference

11 May 2018

miR-126 and miR-126*: new players in cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNA: implications for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNA-34 family, mechanisms of action in cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

miR-126 in human cancers: clinical roles and current perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Downregulation of microRNA-498 in colorectal cancers and its cellular effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Altered JS-2 expression in colorectal cancers and its clinical pathological relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Down-regulation of miR-126 expression in colorectal cancer and its clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Deregulated expression of miR-106a predicts survival in human colon cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

miRDB: an online resource for microRNA target prediction and functional annotations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNA-126 regulates HOXA9 by binding to the homeobox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Endogenous human microRNAs that suppress breast cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MiR-126 suppresses colon cancer cell proliferation and invasion via inhibiting RhoA/ROCK signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

A one-two punch of miR-126/126* against metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

The brain within the tumor: new roles for axon guidance molecules in cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Perineural invasion in cancer: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Survival prediction of gastric cancer by a seven-microRNA signature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Prognostic significance of differentially expressed miRNAs in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Tumor suppressor p53 meets microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Diagnostic and prognostic microRNAs in stage II colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Expression of miR-126 suppresses migration and invasion of colon cancer cells by targeting CXCR4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.10.004

10.1016/J.YEXCR.2015.10.004

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018